Favipiravir

Most drugs for treating adult COVID-19 patients not recommended for children: Check out govt guidelines

Most drugs for treating adult COVID-19 patients not recommended for children: Check out govt guidelines

Drugs such as ivermectin, hydroxychloroquine, favipiravir and antibiotics like doxycycline and azithromycin prescribed for adult COVID-19...Read More

Covid-19: Indore ramps up manufacturing of Favipiravir amid predictions of third wave

Covid-19: Indore ramps up manufacturing of Favipiravir amid predictions of third wave

"Due to shortage of Favipiravir, it was planned to manufacture the medicine in Indore itself. McW Healthcare Company had a method to prod...Read More

COVID-19: Bal Pharma supplies Favipiravir under brand name BALflu for Rs 85 per tablet in India

COVID-19: Bal Pharma supplies Favipiravir under brand name BALflu for Rs 85 per tablet in India

Drug company Bal Pharma will be supplying Favipiravir formulation in India under the brand name BALflu. The company will be selling one t...Read More

COVID-19: Bharat Parenterals gets DCGI nod for favipiravir oral suspension

COVID-19: Bharat Parenterals gets DCGI nod for favipiravir oral suspension

Drug firm Bharat Parenterals on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for favipiravir ...Read More

Vivimed Labs to manufacture, market Favipiravir tablets in India; shares up

Vivimed Labs to manufacture, market Favipiravir tablets in India; shares up

Drug firm Vivimed Labs on Monday said it has received approval from the Director General of Health Services (DGHS) to manufacture and mar...Read More

Bajaj Healthcare to sell Favipiravir for treatment of non-critical COVID-19 patients; shares of BHL gain 10%

Bajaj Healthcare to sell Favipiravir for treatment of non-critical COVID-19 patients; shares of BHL gain 10%

Bajaj Healthcare Limited (BHL) will manufacture Favijaj, popularly known as Favipiravir for treatment of mild to moderate COVID-19 patien...Read More

Highest infection as tests hit new high of 2.42 lakh

Highest infection as tests hit new high of 2.42 lakh

New DelhiA record number of 20,903 persons were found infected with the Covid-19 virus in a day on Friday even as 2,41,576 persons underw...Read More

Indore: Sri Aurobindo Institute of Medical Sciences claims successful use of Remdesivir, Favipiravir

Indore: Sri Aurobindo Institute of Medical Sciences claims successful use of Remdesivir, Favipiravir

SAIMS also used Favipiravir to treat 12 patients with moderate symptoms.

Corona Medicine Update: Glenmark’s Favipiravir is different from Livealth Bio Pharma’s Livfavir

Corona Medicine Update: Glenmark’s Favipiravir is different from Livealth Bio Pharma’s Livfavir

There has been fake news that has been circulated around ‘Favipiravir’ (called Fabiflu in India) which is marketed in India by Glenmark ...Read More

Glenmark stocks surge after nod to launch antiviral drug 'Favipiravir' for mild-to-moderate COVID-19 infections

Glenmark stocks surge after nod to launch antiviral drug 'Favipiravir' for mild-to-moderate COVID-19 infections

Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company...Read More

Glenmark launches COVID-19 drug after DCGI nod

Glenmark launches COVID-19 drug after DCGI nod

Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of ...Read More

Favipiravir gets nod

Favipiravir gets nod

For restricted emergency use in mild to moderate COVID-19 cases

Favipiravir-Umifenovir’s clinical trial will enter phase 3: Glenmark

Favipiravir-Umifenovir’s clinical trial will enter phase 3: Glenmark

On one hand, the pharmaceutical company Glenmark is conducting phase three clinical trials on antiviral Favipiravir as a monotherapy for ...Read More

Strides Pharma to conduct bio-equivalence study on favipiravir in India

Strides Pharma to conduct bio-equivalence study on favipiravir in India

The drug is a generic version of Japan-based Toyama Chemical's Avigan and was initially developed to treat influenza in Japan. It has sho...Read More

Find out which drugs enjoy the fast mover benefit in treating COVID-19 patients

Find out which drugs enjoy the fast mover benefit in treating COVID-19 patients

Every other day, there are talks about drugs like Favipiravir and Remdesivir. Seems like the fast mover, India’s very own anti-malarial m...Read More

Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients

Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients

The Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favi...Read More

Third clinical trials on antiviral Favipiravir for COVID-19 patients initiated

Third clinical trials on antiviral Favipiravir for COVID-19 patients initiated

If the drug is commercialised in India, it will be marketed under the brand name ‘FabiFlu’.

Coronavirus Update from China: China reports new progress in drug, therapies against COVID-19

Coronavirus Update from China: China reports new progress in drug, therapies against COVID-19

China has initiated several clinical research programs on stem cell therapy against COVID-19, including a stem cell drug that has been ap...Read More

Free Press Journal

www.freepressjournal.in